CADILAHC Intraday Analysis...

CADILAHC Share Price

Open 445.00 Change Price %
High 450.20 1 Day -4.05 -0.91
Low 438.00 1 Week 74.35 20.36
Close 439.60 1 Month 80.40 22.38
Volume 1803791 1 Year 112.25 34.29
52 Week High 460.75
52 Week Low 304.20
CADILAHC Important Levels
Resistance 2 450.91
Resistance 1 446.25
Pivot 442.60
Support 1 432.95
Support 2 428.29
NSE INDIA Most Active Stocks
JPASSOCIAT 14.45 -3.99%
JINDALSTEL 109.40 9.24%
RCOM 35.35 2.02%
GMRINFRA 14.95 -3.24%
SUZLON 17.35 1.46%
MFSL 564.85 -5.03%
IDEA 108.35 -0.09%
MARKSANS 50.60 4.12%
UNITECH 5.85 -1.68%
SOUTHBANK 20.80 0.48%
More..
NSE INDIA Top Gainers Stocks
KSERASERA 0.15 50.00%
VKSPL 0.15 50.00%
RASOYPR 0.20 33.33%
VISESHINFO 0.20 33.33%
SALONA 63.00 20.00%
JINDWORLD 220.25 19.99%
SALORAINTL 65.85 19.95%
ISMTLTD 14.75 19.92%
KHAITANELE 41.30 18.68%
MANAKCOAT 9.50 17.28%
More..
NSE INDIA Top Losers Stocks
BIRLACOT 0.05 -50.00%
UJAAS 36.30 -12.42%
SGL 13.05 -7.45%
SGL 13.05 -7.45%
SGL 13.05 -7.45%
SGL 13.05 -7.45%
ZENITHBIR 0.65 -7.14%
UVSL 0.70 -6.67%
KESARENT 56.00 -6.67%
BILENERGY 0.75 -6.25%
More..

Cadila Healthcare Limited (NSE: CADILAHC)

CADILAHC Technical Analysis 5
As on 21st Feb 2017 CADILAHC Share Price closed @ 439.60 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 360.04 & Strong Buy for SHORT-TERM with Stoploss of 369.95 we also expect STOCK to react on Following IMPORTANT LEVELS.
CADILAHC Target for February
1st Target up-side 379.11
2nd Target up-side 399.12
3rd Target up-side 419.14
1st Target down-side 321.99
2nd Target down-side 301.98
3rd Target down-side 281.96
CADILAHC Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is Above 70 Over Bought
MFI (14) MFI is 77.55 Sideways
CCI (20) CCI is Above 100 Over Bought
WILLIAM %R (14) William %R is Above -20 Over Bought
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 352.46
10 Day Avg Volume Traded -37.09 % Less then 10 Day Average Volume
CADILAHC Other Details
Segment EQ
Market Capital 40527183872.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.zyduscadila.com
CADILAHC Address
CADILAHC
Zydus Tower
Satellite Cross Roads
Ahmedabad, 380015
India
Phone: 91 79 2686 8100
Fax: 91 79 2686 2365
Interactive Technical Analysis Chart Cadila Healthcare Limited ( CADILAHC NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cadila Healthcare Limited
CADILAHC Business Profile
Cadila Health is in the Pharmaceuticals sector. Cadila Laboratories was founded in 1952 by Ramanbhai Patel(1952–2001), formerly a lecturer in the L.M. College of Pharmacy, and his business partner Shri Indravadan Modi. The company evolved over the next four decades into one of India's established pharmaceutical companies. In 1995 the Patel and Modi families split, with the Modi family's share being moved into a new company called Cadila Pharmaceuticals Ltd. and Cadila Healthcare became the Patel family's holding company. Cadila Healthcare did its IPO on the Bombay Stock Exchange in 2000. Its stock code on the Bombay exchange is 532321. In 2001 the company acquired another Indian pharmaceutical company called German Remedies. On June 25, 2007, the company signed an agreement to acquire 100 per cent stake in Brazil's Quimica e Farmaceutica Nikkho do Brasil Ltda (Nikkho) for around 26 million dollars. In 2010, Cadila Pharmaceuticals received a prestigious Wellcome Trust Award under the new "R&D for Affordable Healthcare in India" initiative. The current market capitalisation stands at Rs 15,310.07 crore.The company has reported a consolidated sales of Rs 1746.79 crore and a Net Profit of Rs 191.57 crore for the quarter ended Sep 2013. The company management includes Pankaj R Patel - Chairman & Managing Director, Sharvil P Patel - Deputy Managing Director, Humayun Dhanrajgir - Director, Mukesh M Patel - Director, Nitin R Desai - Director, Apurva S Diwanji - Director. It is listed on the BSE with a BSE Code of 532321 and the NSE with an NSE Code of CADILAHC. Its Registered office is at "Zydus Tower", Satellite Cross Roads,,Sarkhej Gandhinagar Highway Ahmedabad,Gujarat - 380015.